Gemcitabine AqVida 1 gm/vial (IV Infusion)
1 gm vial: ৳ 7,029.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Gemcitabine |
| Company | Aqvida gmbh |
| Also available as |
Indications
- Non-Small Cell Lung Cancer
- Pancreatic Cancer
- Bladder Cancer
- Breast Cancer
- Ovarian Cancer
Pharmacology
- Metabolized intracellularly by nucleoside kinases
- Inhibition of DNA synthesis
- Cytotoxic action
- Induces programmed cellular death process
Dosage & Administration
- Recommended doses for different types of cancer
- Intravenous infusion
- Dosage reduction based on toxicity experienced by the patient
Interaction
- No confirmed interactions reported
- No specific drug interaction studies conducted
Contraindications
- Contraindicated in patients with known hypersensitivity to Gemcitabine or any other components
Side Effects
- Haematological Toxicity
- Hepatic Toxicity
- Gastrointestinal Toxicity
- Genito-Urinary Toxicity
- Pulmonary Toxicity
- Allergic Toxicity
- Neurotoxicity
- Alopecia
Pregnancy & Lactation
- Pregnancy Category D
- Excretion in human breast milk unknown
Precautions & Warnings
- Caution in patients with risk of Schedule-dependent Toxicity
- Myelosuppression
- Pulmonary Toxicity and Respiratory Failure
- Hemolytic Uremic Syndrome
- Hepatic Toxicity
- Embryofetal Toxicity
- Radiation Therapy Toxicity
- Impairment of Fertility
Use in Special Populations
- Elderly Patients
- Renal and Hepatic Impairment
- Children
Overdose Effects
- No known antidote
- Principal toxicities seen when a single high dose administered
Therapeutic Class
- Cytotoxic Chemotherapy
Storage Conditions
- Store in original carton at 20° to 25°C
- Do not refrigerate as crystallisation may occur
- Keep out of reach of children